These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 36620592)

  • 1. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.
    Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP
    Front Oncol; 2022; 12():1094248. PubMed ID: 36620592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of neutrophil extracellular trap signature in clear cell renal cell carcinoma.
    Li R; Jiang X; Wang P; Liu X
    Front Oncol; 2023; 13():1205713. PubMed ID: 37519809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction.
    Tai R; Leng J; Li W; Wu Y; Yang J
    BMC Urol; 2023 Sep; 23(1):147. PubMed ID: 37715154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma.
    Wei X; Zhang X; Wang S; Wang Y; Ji C; Yao L; Song N
    Am J Cancer Res; 2022; 12(8):3780-3798. PubMed ID: 36119844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y; He J; Jin T; Zhang Y; Ou Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma.
    Gui Z; Du J; Wu N; Shen N; Yang Z; Yang H; Wang X; Zhao N; Zeng Z; Wei R; Ma W; Wang C
    BMC Cancer; 2023 Jul; 23(1):649. PubMed ID: 37438709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of m
    Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
    Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an interferon regulatory factors-related risk model for predicting prognosis, immune microenvironment and immunotherapy in clear cell renal cell carcinoma.
    Pan H; Lu W; Zhang M; Liu C
    Front Oncol; 2023; 13():1131191. PubMed ID: 37182129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis.
    Wang S; Wei X; Ji C; Wang Y; Zhang X; Cong R; Song N
    Front Oncol; 2022; 12():781932. PubMed ID: 35356208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of a tryptophan metabolism-related model in the prognostic prediction and immune status for clear cell renal carcinoma.
    Yao Q; Zhang X; Wang Y; Wang C; Wei C; Chen J; Chen D
    Eur J Med Res; 2024 Jan; 29(1):22. PubMed ID: 38183155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma.
    Yao Q; Zhang X; Wei C; Chen H; Xu Q; Chen J; Chen D
    Heliyon; 2023 Jun; 9(6):e17224. PubMed ID: 37360096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
    Hu D; Zhou M; Zhu X
    Biomed Res Int; 2019; 2019():2506843. PubMed ID: 31886185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A signature based on m6A pattern and tumor microenvironment infiltration in clear cell renal cell carcinoma.
    Yang C; Yu T; Li Q; Xie F; Lin Q
    Am J Transl Res; 2022; 14(7):4931-4947. PubMed ID: 35958449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy.
    Zhong W; Li Y; Yuan Y; Zhong H; Huang C; Huang J; Lin Y; Huang J
    Front Cell Dev Biol; 2021; 9():736540. PubMed ID: 34631713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
    Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
    Front Immunol; 2022; 13():934243. PubMed ID: 36189255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 18. Establishment of a Seven-Gene Signature Associated with CD8
    Chen Y; Zhou X; Xie Y; Wu J; Li T; Yu T; Pang Y; Du W
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and implementation of a prognostic model for clear cell renal cell carcinoma based on heterogeneous TLR4 expression.
    Zhou Q; Sun Q; Shen Q; Li X; Qian J
    Heliyon; 2024 Feb; 10(4):e25571. PubMed ID: 38380017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.